Andrew C. Orth - 31 May 2021 Form 4 Insider Report for Krystal Biotech, Inc. (KRYS)

Role
Chief Commercial Officer
Signature
/s/ Krish Krishnan, by power of attorney
Issuer symbol
KRYS
Transactions as of
31 May 2021
Net transactions value
$0
Form type
4
Filing time
02 Jun 2021, 19:19:42 UTC
Previous filing
11 May 2021
Next filing
01 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding KRYS Common Stock 100 31 May 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRYS Stock Option (Right to Buy) Award $0 +205,000 $0.000000 205,000 31 May 2021 Common Stock 205,000 $65.24 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in four equal annual installments beginning on May 3, 2022.